The polymerase chain reaction (PCR) technique was used to detect Mycoplasma pneumoniae. A specific DNA sequence for M. pneumoniae was selected from a genomic library, and two oligonucleotides were chosen in this sequence to give an amplified fragment of 144 base pairs. We show that DNA from different M. pneumoniae strains can be detected by PCR, with DNA from other Mycoplasma species giving negative results. Analysis of biological samples (throat swabs) obtained from hamsters that were experimentally infected with M. pneumoniae showed that PCR was more sensitive and reliable than conventional culture techniques for the detection of M. pneumoniae. Initial experiments on artificially seeded human bronchoalveolar lavages showed that PCR can be used to detect 102 to 103 organisms.
Mycoplasma pneumoniae is responsible for a wide spectrum of respiratory diseases. Most of them are mild infections. However, this pathogen is an important cause of primary atypical pneumonia; thus, the development of a highly sensitive microbiological diagnostic method is worthwhile. Two methods are currently used for this purpose: serological procedures or isolation of the organism by culture (3, 5) . The cultivation of M. pneumoniae, a fastidious microorganism, is time-consuming and may require 3 weeks for results. Serological procedures are the most widely used and require the demonstration of a rise in antibody titer. It takes too long for results of both of these diagnostic methods to be obtained to allow for the rapid application of an effective treatment.
Hybridization with DNA probes has been proposed as a rapid and specific procedure to replace the culture method for detecting M. pneumoniae (7, 10) . Unfortunately, this procedure lacks sensitivity. Furthermore, most of the probes use radioactive labeling, a technique that is unapplicable for diagnosis on a widespread basis.
Recently, an in vitro technique was developed to amplify short segments of DNA. This is referred to as the polymerase chain reaction (PCR) (18) . Two primers that flank the region to be amplified are used with this technique, which is based on repeated cycles of denaturation, annealing of primers, and primer extension by a DNA polymerase. This results in the exponential accumulation of the target sequence copies. This technique has already been used for the diagnosis of genetic diseases (17) and viral infections (16) . It is also an effective tool for bacteriological diagnosis (6, 15) .
We report here the enzymatic amplification by PCR of a specific DNA fragment of M. pneumoniae. Enzymatic amplification was performed under different conditions and was applied to several M. pneumoniae isolates and to dilutions of the organism in bronchoalveolar lavages (BALs). Furthermore, PCR was compared with the classical culture method for the detection of M. pneumoniae in experimentally infected animals. * Corresponding author.
MATERIALS AND METHODS
Organisms and clinical specimens. M. pneumoniae FH and PI 1428, five M. pneumoniae clinical isolates, Mycoplasma hominis PG21, Mycoplasma salivarium PG20, Mycoplasma orale CH 19299, Mycoplasma buccale CH 20247, and Acholeplasma laidlawii PG8 were grown on the modified medium described by Hayflick (9) . Mycoplasma genitalium G37 was grown on SP4 medium (21) . BALs were obtained from hospitalized patients.
DNA extraction. A total of 250 ml of a late-exponentialphase culture of mycoplasmas was centrifuged for 30 min at 10,000 x g. The pellet was suspended in 5 ml of STE buffer (10 mM NaCl, 20 mM Tris hydrochloride [pH 8 .0], 1 mM EDTA) and incubated overnight at 37°C with 1% sodium dodecyl sulfate and 50 tg of proteinase K (Boehringer GmbH, Mannheim, Federal Republic of Germany) per ml. DNA was extracted three times with an equal volume of phenol saturated with TE (10 mM Tris hydrochloride [pH 7.5], 1 mM EDTA), once with phenol-chloroform-isoamylic alcohol (10:9.6:0.4; vol/vol/vol), and once with chloroformisoamylic alcohol (9.6:0.4; vol/vol). The aqueous phase was made to 0.3 M CH3COONa, and the DNA was precipitated with 2 volumes of absolute ethanol. The nucleic acids were suspended in TE buffer and were treated with DNase-free RNase A (50 ,ug/ml) at 37°C for 30 min. After another extraction with phenol and ethanolic precipitation, the DNA was suspended in TE buffer.
For experiments with Escherichia coli, the suspended cell pellet was incubated with 50 ,ug of lysozyme per ml at 37°C
for 60 min and treated as described above. Human DNA was extracted from blood as described previously (11 16 h in the same mixture but containing nick-translated, 32P-labeled probes (13) . After hybridization, the filters used for dot blot hybridization were washed at 65C as follows: twice for 15 min in 2x SSPE, once for 30 min in 2x SSPE-0.1% sodium dodecyl sulfate, and once for 10 min in 0.lx SSPE. The blots were autoradiographed with an intensifying screen.
Infection of hamsters and specimen sampling. Hamsters were inoculated intranasally with 0.2 ml of an M. pneumoniae PI 1428 suspension in its eighth passage on the medium described by Hayflick (9) . The suspension contained 107 color-changing units (CCU) of M. pneumoniae per ml (3) . Before and at various times after inoculation, two throat swab specimens were collected. One was placed in 0.5 ml of the medium described by Hayflick (9) and was used for the culture detection of M. pneumoniae. The other one was placed in 0.5 ml of TE buffer containing 1% sodium dodecyl sulfate and 50 ,ug of proteinase K per ml. After a 2-h incubation at 37°C, an equal volume of phenol was added and the tubes were kept at -80°C until analysis. Before use, each sample was centrifuged, the aqueous phase was extracted twice with chloroform, and then the solution was made to 0.1 M NaCI and DNA was precipitated with 2 volumes of ethanol.
BAL specimen analysis. BAL specimens (10 to 20 ml) were concentrated to 1 ml by centrifugation and analyzed by both the conventional culture method on the medium described by Hayflick (9) and by using the PCR.
Amplification experiments were conducted on 10 ,ul of these BAL samples without any extraction, with or without 10 ,ul of a serial dilution of an M. pneumoniae culture. Samples for amplification were then treated as described above.
Amplification. Amplification was performed with the ther- polyacrylamide gel (13) .
Analysis of amplified DNA samples. Analysis of amplified DNA samples was performed on an 8% polyacrylamide gel in Tris borate buffer (13) . DNA was visualized by UV fluorescence after it was stained with ethidium bromide. Southern transfer was carried out as described previously (20) . Hybridization with a nick-translated, 32P-labeled DNA probe was performed as described above for the dot blot hybridization procedure. Hybridization with the 5'-end-labeled MP5-4 oligonucleotide was carried out at 50°C (13) . After hybridization, filters were washed three times in 5x SSPE at 50°C for 20 min.
RESULTS
Isolation of a specific DNA sequence of M. pneumoniae. A genomic library of M. pneumoniae was constructed in the Blue-Scribe plasmid vector. A sequence from this library was demonstrated to be specific for M. pneumoniae by dot blot hybridization (Fig. 1A) . The DNA targets were total DNA populations from M. pneumoniae and various other species generally found in the human respiratory tract and from M. genitalium, which is the closest known organism to M. pneumoniae (22) . The MP5 clone gave a positive hybridization signal only with M. pneumoniae DNA. This clone was sequenced by the dideoxynucleotide chain-termination method (19) . The nucleotide sequence is shown in Fig. 1B (Fig. 2A, lanes 3 to 7) .
Southern analysis with 32P-labeled MP5 cloned DNA was used to control the specificity of the amplified fragment (Fig.  2B) . A hybridization signal was observed with the 144-bp fragment that was obtained with DNA from MP5 and M. pneumoniae strains (Fig. 2B, lanes 1, 2, and 8 to 10 ). DNAs from other species did not yield any signal (Fig. 2B, lanes 3  to 7) . Further control experiments were performed under the same conditions with DNA from a variety of microorganisms that are likely to be found in the human respiratory tract. These microorganisms included Staphylococcus aureus, Haemophilus influenza, Streptococcus faecalis, Lactobacillus species, Peptostreptococcus anaerobius, Pseudomonas aeruginosa, and Klebsiella pneumoniae. No signals were observed (data not shown).
DNA amplification of biological samples. Throat swabs from hamsters that were experimentally infected with M. pneumoniae PI 1428 were analyzed by both the conventional culture method and PCR. Samples obtained before infection or n days after infection were amplified, and the products of amplification were analyzed on polyacrylamide gels. Results of a typical experiment are shown in Fig. 3A for two hamsters (H3 and H5 in lanes 2 to 6 and 7 to 9, respectively) and for DNA from MP5 plasmid DNA (lane 1). The specificity was confirmed (Fig. 3B) (Fig. 3 , lanes 7 to 9).
Amplification on BAL specimens. Amplifications that were first conducted on a series of 20 BAL specimens gave negative results, in agreement with results of the conventional culture method (data not shown). To check the sensitivity of PCR on these samples, we added 10 CCU (Fig. 4A,   lanes 4 and 7) , 100 CCU (Fig. 4A, lanes 3 and 6) , and 1,000 CCU (Fig. 4A, lanes 2 and 5) of M. pneumoniae cells to one of the samples before amplification (1 CCU was estimated to be equivalent to 10 to 100 Mycoplasma particles). On the ethidium bromide-stained gel, a 144-bp DNA band was visualized for 100 and 1,000 CCU (Fig. 4A, lanes 2, 3, 5, and   6 ). Southern analysis ofthese products showed (Fig. 4B ) that this band hybridized with the MP5-4 oligonucleotide which was complementary to part of the amplified sequence, confirming the specificity of the amplification. Furthermore, the same band was also detected in the amplification product of the 10-CCU sample (Fig. 4B, lanes 4 and 7) .
DISCUSSION
With the aim of improving the diagnosis of M. pneumoniae infection, we applied the PCR technique to this study. We first randomly cloned small M. pneumoniae genomic sequences. One of them was found by dot blot hybridization analysis to hybridize specifically to M. pneumoniae DNA.
Then, two oligonucleotides complementary to two flanking sequences of a 144-nucleotide-long fragment were synthesized and used as primers for PCR.
We showed that DNA amplification allows for the detection of M. pneumoniae FH DNA. DNA from a set of M. pneumoniae strains (PI 1428 and clinical isolates) also gave consistently positive signals. Human DNA, DNA from species generally found in the respiratory tract, and M. genitalium DNA gave negative results. Altogether, these data show that our PCR assay allows for the specific and sensitive detection of M. pneumoniae DNA.
The validity of the assay was then checked by using hamsters as an animal model. In this case, experimental infection could be controlled by the classical culture method. This also allowed a comparison of PCR and the culture method as detection tools. We found PCR to be more sensitive and more reproducible than the culture method, and the PCR was completely unaffected by bacterial contamination.
BAL is an accepted technique for diagnosing pulmonary diseases (12) . In preliminary experiments with 25 cycles of amplification, we were able to consistently and specifically detect 10 CCU of M. pneumoniae (i.e., 102 to 103 organisms), in comparison with 103 to 105 organisms, which is the limit of detection with radioisotopically labeled DNA probes (7, 10) .
Thus, with our assay we were able to detect with a high sensitivity and specificity all of the M. pneumoniae strains that we tested. Moreover, the assay was convenient and fast enough to be used on a routine basis and can be made more sensitive, if necessary, by increasing the number of cycles.
We are currently validating the assay on a large number of clinical samples.
